Neurology News

ORLANDO, Fla. — Among a cohort of patients within the Atherosclerosis Risk in Communities study, no link was found between late-life depression and global amyloid deposition, according to a poster at the American Neurological Association.

The 2024 election is one of the most consequential elections in recent history, and as physicians, we have a responsibility to vote.

The FDA has granted 510(k) clearance to a Centiloid scaling apparatus software for positron emission tomography-based amyloid imaging to evaluate individuals for Alzheimer’s disease-related pathology.

Most physicians and residents report feelings of burnout, while stigma about receiving mental health care remains prevalent, according to a new report from The Physicians Foundation.

A nurse-supported cognitive behavioral therapy intervention for insomnia reduced symptoms and improved sleep outcomes in veterans, results from a randomized study published in JAMA Internal Medicine showed.

ORLANDO, Fla. — The COVID-19 pandemic likely altered stroke patient characteristics, as those admitted to the hospital were younger and had more severe symptoms over a 2-year post-pandemic interval, according to a poster.

ORLANDO, Fla. — Patients with MS who developed paramagnetic rim lesions declined more rapidly, but implementing disease-modifying therapies earlier could reduce the burden of disease progression, data show.

A Korean study identified a 22% increased risk for seizure among young children who were prescribed first-generation antihistamines, according to findings published in JAMA Network Open.

Patients with preclinical Alzheimer’s disease had significantly greater putative retinal gliosis compared with controls, according to study results published in Investigative Ophthalmology & Visual Science.